Product Manager, Ultivue
BIOGRAPHY
APR 16, 2020 9:00 AM PDT
A new fluorescent multiplex IHC phenotyping platform for fast hypothesis testing of the tumor microenvironment (copy)
Speaker
Date & Time
DATE: April 16, 2020
TIME: 9:00am PT, 12:00pm ET
Abstract
There is an increasing need to evaluate and understand unique phenotypes and mechanisms of action within the tumor microenvironment. Existing technologies allow researchers to either perform an in-depth investigation of tissue samples (that can take a long time) or a quick assay (that does not provide the necessary amount of data for a comprehensive study). However, with Ultivue's new platform, researchers and scientists will be able to experience an in-depth level of cellular phenotyping data in an assay format that enables high-throughput hypothesis testing. This webinar will explore the new technology platform and feature sample data and results that can be achieved through the new product offering.
Learning Objectives:
- Understand the workflow associated for > 4-plex fluorescent IHC assays
- Articulate the advantages of same-cell marker expression for deep phenotyping
Webinars will be available for unlimited on-demand viewing after live event.
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.
You May Also Like
JAN 14, 2026 | 10:00 AM
Join us for an insightful webinar to discuss a holistic approach to testing for TB in a clinical setting. Tuberculosis remains a global health challenge and accurate, timely diagnosis is cri...
JAN 15, 2026 | 8:00 AM
Personalized medicine promises to significantly improve patient outcomes, but achieving this requires a deep understanding of human health and disease mechanisms at the molecular level. The...
JAN 20, 2026 | 11:00 AM
CAR-T translational research demands precise, reproducible, and scalable flow cytometry workflows. Manual centrifugation and antibody preparation steps remain major sources of variability an...
JAN 20, 2026 | 9:15 AM
Bloodstream infections (BSIs) remain a critical challenge in clinical care, where every hour of delay in diagnosis can significantly impact patient outcomes. This webinar explores findings f...
JAN 21, 2026 | 8:45 AM
C.E. CREDITS
Lipid nanoparticles (LNPs) have become the gold standard in non-viral gene delivery technologies, exemplified by the approval of the LNP messenger RNA (mRNA) vaccines against SARS-CoV-2. Sin...
JAN 22, 2026 | 8:00 AM
Cell line development (CLD) is often a critical bottleneck in biopharmaceutical production, often requiring labor-intensive workflows and multiple sequential screening steps that extend time...
Loading Comments...